97 related articles for article (PubMed ID: 28447753)
1. Antitumor activity of fucoidan in anaplastic thyroid cancer via apoptosis and anti-angiogenesis.
Shen HY; Li LZ; Xue KC; Hu DD; Gao YJ
Mol Med Rep; 2017 May; 15(5):2620-2624. PubMed ID: 28447753
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of Pulsatilla koreana extract in anaplastic thyroid cancer via apoptosis and anti-angiogenesis.
Park BH; Jung KH; Son MK; Seo JH; Lee HS; Lee JH; Hong SS
Mol Med Rep; 2013 Jan; 7(1):26-30. PubMed ID: 23135100
[TBL] [Abstract][Full Text] [Related]
3. Fucoidan inhibits angiogenesis induced by multiple myeloma cells.
Liu F; Luo G; Xiao Q; Chen L; Luo X; Lv J; Chen L
Oncol Rep; 2016 Oct; 36(4):1963-72. PubMed ID: 27498597
[TBL] [Abstract][Full Text] [Related]
4. Fucoidan extract derived from Undaria pinnatifida inhibits angiogenesis by human umbilical vein endothelial cells.
Liu F; Wang J; Chang AK; Liu B; Yang L; Li Q; Wang P; Zou X
Phytomedicine; 2012 Jun; 19(8-9):797-803. PubMed ID: 22510492
[TBL] [Abstract][Full Text] [Related]
5. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
6. LncRNA-MALAT1 Promotes Angiogenesis of Thyroid Cancer by Modulating Tumor-Associated Macrophage FGF2 Protein Secretion.
Huang JK; Ma L; Song WH; Lu BY; Huang YB; Dong HM; Ma XK; Zhu ZZ; Zhou R
J Cell Biochem; 2017 Dec; 118(12):4821-4830. PubMed ID: 28543663
[TBL] [Abstract][Full Text] [Related]
7. CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo.
Antonelli A; Bocci G; La Motta C; Ferrari SM; Fallahi P; Ruffilli I; Di Domenicantonio A; Fioravanti A; Sartini S; Minuto M; Piaggi S; Corti A; Alì G; Di Desidero T; Berti P; Fontanini G; Danesi R; Da Settimo F; Miccoli P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E528-36. PubMed ID: 22278419
[TBL] [Abstract][Full Text] [Related]
8. CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo.
Antonelli A; Bocci G; Fallahi P; La Motta C; Ferrari SM; Mancusi C; Fioravanti A; Di Desidero T; Sartini S; Corti A; Piaggi S; Materazzi G; Spinelli C; Fontanini G; Danesi R; Da Settimo F; Miccoli P
J Clin Endocrinol Metab; 2014 Apr; 99(4):E572-81. PubMed ID: 24423321
[TBL] [Abstract][Full Text] [Related]
9. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo.
Oliveira C; Granja S; Neves NM; Reis RL; Baltazar F; Silva TH; Martins A
Carbohydr Polym; 2019 Nov; 223():115034. PubMed ID: 31426965
[TBL] [Abstract][Full Text] [Related]
11. Fucoidan-Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Co-Targeting Tumor Hypoxia and Angiogenesis.
Shin SW; Jung W; Choi C; Kim SY; Son A; Kim H; Lee N; Park HC
Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30558324
[TBL] [Abstract][Full Text] [Related]
12. Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia.
Chen MC; Hsu WL; Hwang PA; Chou TC
Mar Drugs; 2015 Jul; 13(7):4436-51. PubMed ID: 26193287
[TBL] [Abstract][Full Text] [Related]
13. Anticancer Effect of Fucoidan on DU-145 Prostate Cancer Cells through Inhibition of PI3K/Akt and MAPK Pathway Expression.
Choo GS; Lee HN; Shin SA; Kim HJ; Jung JY
Mar Drugs; 2016 Jul; 14(7):. PubMed ID: 27399727
[TBL] [Abstract][Full Text] [Related]
14. Fucoidan from Laminaria japonica exerts antitumor effects on angiogenesis and micrometastasis in triple-negative breast cancer cells.
Hsu WJ; Lin MH; Kuo TC; Chou CM; Mi FL; Cheng CH; Lin CW
Int J Biol Macromol; 2020 Apr; 149():600-608. PubMed ID: 32004612
[TBL] [Abstract][Full Text] [Related]
15. Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes.
Straight AM; Oakley K; Moores R; Bauer AJ; Patel A; Tuttle RM; Jimeno J; Francis GL
Cancer Chemother Pharmacol; 2006 Jan; 57(1):7-14. PubMed ID: 16001179
[TBL] [Abstract][Full Text] [Related]
16. A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway.
Li GY; Jung KH; Lee H; Son MK; Seo J; Hong SW; Jeong Y; Hong S; Hong SS
Cancer Lett; 2013 Feb; 329(1):59-67. PubMed ID: 23085493
[TBL] [Abstract][Full Text] [Related]
17. Fucoidan/FGF-2 induces angiogenesis through JNK- and p38-mediated activation of AKT/MMP-2 signalling.
Kim BS; Park JY; Kang HJ; Kim HJ; Lee J
Biochem Biophys Res Commun; 2014 Aug; 450(4):1333-8. PubMed ID: 25003321
[TBL] [Abstract][Full Text] [Related]
18. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
[TBL] [Abstract][Full Text] [Related]
19. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis.
Dewangan J; Kaushik S; Rath SK; Balapure AK
Life Sci; 2018 Jan; 193():9-19. PubMed ID: 29196053
[TBL] [Abstract][Full Text] [Related]
20. DCLAK11, a multi-tyrosine kinase inhibitor, exhibits potent antitumor and antiangiogenic activity in vitro.
Guo XB; Chen XJ; Tong LJ; Peng X; Huang M; Liu HC; Liu H; Ding J
Acta Pharmacol Sin; 2015 Oct; 36(10):1266-76. PubMed ID: 26027659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
